Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple oral therapy with bempedoic acid vs usual care in early lipid management of patients with acute coronary syndrome
2026-525740-15-00Phase 3Authorised
- Sponsor
- Fondazione per il Tuo cuore
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bempedoic acid in acute coronary syndrome (ACS) and hypercholesterolemia (2 arms), sponsored by Fondazione per il Tuo cuore. Planned start Jul 2026; status: authorised.
02
Drugs
bempedoic acid
03
Conditions
acute coronary syndrome (ACS)hypercholesterolemia
Beyond the preview
Go deeper on 2026-525740-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525740-15-00.